tirzepatide/zepbound Lilly launches lower-price weight-loss drug Zepbound without injector pen Zepbound® Vial | Hims

The 24% average weight loss at 48 weeks makes this trade-off remarkably favorable for most people

Mounjaro does not contain sulfonamides or sulfa drugs

Estamos simplificando lo complejo

Weight loss on GLP-1 RAs is accompanied by improvements in cardiometabolic markers (glycemia, lipids, blood pressure) and has spurred investigation of GLP-1 RA therapy for obesity itself, independent of diabetes

We found the clinical studies on GLP-1RAs to be at a low risk of bias given high JBI scores, however, they lacked the characteristics to answer our primary research question

Takeaway If youre considering Tirzepatide as a treatment option or are already on this medication and have questions about timing, side effects , or management, dont hesitate to reach out to Timeless Skin and Wellness & Weight Loss